These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21763744)

  • 61. COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells.
    Park J; Jeong JY; Kang SS
    Anticancer Res; 2022 Dec; 42(12):5773-5781. PubMed ID: 36456159
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Replication Stress: An Achilles' Heel of Glioma Cancer Stem-like Cells.
    Morgan MA; Canman CE
    Cancer Res; 2018 Dec; 78(24):6713-6716. PubMed ID: 30498082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biological effects of selective COX-2 inhibitor NS398 on human glioblastoma cell lines.
    Palumbo P; Lombardi F; Augello FR; Giusti I; Dolo V; Leocata P; Cifone MG; Cinque B
    Cancer Cell Int; 2020; 20():167. PubMed ID: 32435158
    [TBL] [Abstract][Full Text] [Related]  

  • 64. COX-2 overexpression increases malignant potential of human glioma cells through Id1.
    Xu K; Wang L; Shu HK
    Oncotarget; 2014 Mar; 5(5):1241-52. PubMed ID: 24659686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immune cell infiltration and inflammatory landscape in primary brain tumours.
    Luce A; Abate M; Scognamiglio G; Montella M; Iervolino D; Campione S; Di Mauro A; Sepe O; Gigantino V; Tathode MS; Ferrara G; Monaco R; De Dominicis G; Misso G; Gentile V; Franco R; Zappavigna S; Caraglia M
    J Transl Med; 2024 May; 22(1):521. PubMed ID: 38816839
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Breast Cancer Stem Active Cobalt(III)-Cyclam Complex Containing Flufenamic Acid with Immunogenic Potential.
    Fang J; Orobator ON; Olelewe C; Passeri G; Singh K; Awuah SG; Suntharalingam K
    Angew Chem Int Ed Engl; 2024 Feb; 63(6):e202317940. PubMed ID: 38063406
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression.
    Chen Z; Giotti B; Kaluzova M; Vallcorba MP; Rawat K; Price G; Herting CJ; Pinero G; Cristea S; Ross JL; Ackley J; Maximov V; Szulzewsky F; Thomason W; Marquez-Ropero M; Angione A; Nichols N; Tsankova NM; Michor F; Shayakhmetov DM; Gutmann DH; Tsankov AM; Hambardzumyan D
    J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37733448
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fluoride in the Central Nervous System and Its Potential Influence on the Development and Invasiveness of Brain Tumours-A Research Hypothesis.
    Żwierełło W; Maruszewska A; Skórka-Majewicz M; Gutowska I
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675073
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidemiology of Glioblastoma Multiforme-Literature Review.
    Grochans S; Cybulska AM; Simińska D; Korbecki J; Kojder K; Chlubek D; Baranowska-Bosiacka I
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626018
    [TBL] [Abstract][Full Text] [Related]  

  • 70. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
    Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
    BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cyclooxygenase inhibition attenuates brain angiogenesis and independently decreases mouse survival under hypoxia.
    Seeger DR; Golovko SA; Grove BD; Golovko MY
    J Neurochem; 2021 Jul; 158(2):246-261. PubMed ID: 33389746
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of anesthesia and analgesia techniques on glioblastoma progression. A narrative review.
    Privorotskiy A; Bhavsar SP; Lang FF; Hu J; Cata JP
    Neurooncol Adv; 2020; 2(1):vdaa123. PubMed ID: 33205044
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The molecular mechanisms of celecoxib in tumor development.
    Wen B; Wei YT; Mu LL; Wen GR; Zhao K
    Medicine (Baltimore); 2020 Oct; 99(40):e22544. PubMed ID: 33019464
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies.
    Harguindey S; Polo Orozco J; Alfarouk KO; Devesa J
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480530
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Significance of cyclooxygenase-2, prostaglandin E2 and CD133 levels in sunitinib-resistant renal cell carcinoma.
    Luo L; Liang Y; Ding X; Ma X; Zhang G; Sun L
    Oncol Lett; 2019 Aug; 18(2):1442-1450. PubMed ID: 31423209
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of statins or NSAIDs and survival of patients with high-grade glioma.
    Seliger C; Schaertl J; Gerken M; Luber C; Proescholdt M; Riemenschneider MJ; Leitzmann MF; Hau P; Klinkhammer-Schalke M
    PLoS One; 2018; 13(12):e0207858. PubMed ID: 30507932
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polypyridyl Zinc(II)-Indomethacin Complexes with Potent Anti-Breast Cancer Stem Cell Activity.
    Rundstadler TK; Eskandari A; Norman SM; Suntharalingam K
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30181492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.
    Jalota A; Kumar M; Das BC; Yadav AK; Chosdol K; Sinha S
    Oncotarget; 2018 Apr; 9(26):18351-18366. PubMed ID: 29719610
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between nonsteroidal anti-inflammatory drugs use and risk of central nervous system tumors: a dose-response meta analysis.
    Zhang T; Yang X; Liu P; Zhou J; Luo J; Wang H; Li A; Zhou Y
    Oncotarget; 2017 Nov; 8(60):102486-102498. PubMed ID: 29254264
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma.
    Wu M; Guan J; Li C; Gunter S; Nusrat L; Ng S; Dhand K; Morshead C; Kim A; Das S
    Oncotarget; 2017 Oct; 8(47):82217-82230. PubMed ID: 29137258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.